By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Infectious Disease Research Institute (IDRI) 

1124 Columbia Street
Suite 400
Seattle  Washington  98104  U.S.A.
Phone: 206-381-0883 Fax: 206-381-3678


SEARCH JOBS








Company News
Infectious Disease Research Institute (IDRI) Receives $15 Million Commitment From Eli Lilly (LLY) For TB Drug Discovery 11/3/2016 7:48:20 AM
Infectious Disease Research Institute (IDRI) Receives FDA Grant To Develop RNA-Based Zika Virus Vaccine 10/7/2016 6:44:17 AM
Infectious Disease Research Institute (IDRI) Adds Viral Vaccine Development Expertise; Expands Leadership 4/13/2016 8:40:51 AM
Infectious Disease Research Institute (IDRI) And Sanofi Pasteur (SASY.PA) Team With Philanthropy To Develop New Model For Vaccine Development 10/15/2015 9:52:49 AM
Infectious Disease Research Institute (IDRI) And Wellcome Trust Team For Tuberculosis Vaccine Trial In South Africa 9/17/2015 8:21:22 AM
Amyris, Inc. And Infectious Disease Research Institute (IDRI) Announce Agreement To Explore Testing And Development Of Amyris Materials For Use In Vaccine Adjuvant Formulations 9/9/2015 7:35:17 AM
Infectious Disease Research Institute (IDRI) Announces $4M Biomedical Advanced Research and Development Authority (BARDA) Cooperative Agreement To Establish Adjuvant Hub 2/19/2015 8:42:42 AM
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/20/2014 6:09:18 AM
Infectious Disease Research Institute (IDRI) Announces $11.9M Contract To Develop Thermostable TB Vaccine 11/19/2014 11:36:35 AM
Infectious Disease Research Institute (IDRI) and Zydus Sign Agreement for Development of IDRI's Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar) 7/25/2013 9:52:03 AM
12345
//-->